Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5421858 | 6390508 | I | 5421858-3 | 20070807 | 20070820 | EXP | 2007SP016175 | SCHERING-PLOUGH CORPORATION | 63 | YR | M | N | 20070815 | MD | ISRAEL |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5421858 | 1008833726 | PS | INTERFERON ALFA-2B RECOMBINANT (S-P) (INTERFERON ALFA-2B) | 2 | INTRAVENOUS | 18 MIU; QD; IV | D | D | |||
| 5421858 | 1008843376 | C | CYCLOPHOSPHAMIDE | 1 | |||||||
| 5421858 | 1008843377 | C | ADRIAMYCIN PFS | 1 | |||||||
| 5421858 | 1008843378 | C | VINCRISTINE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5421858 | 1008833726 | MALIGNANT MELANOMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5421858 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5421858 | CARDIAC FAILURE CONGESTIVE |
| 5421858 | CARDIOMYOPATHY |
| 5421858 | CARDIOTOXICITY |
| 5421858 | HEPATIC ENZYME INCREASED |
| 5421858 | HYPOTENSION |
| 5421858 | LEFT VENTRICULAR DYSFUNCTION |
| 5421858 | MITRAL VALVE INCOMPETENCE |
| 5421858 | PLEURAL EFFUSION |
| 5421858 | PLEUROPERICARDITIS |
| 5421858 | TACHYPNOEA |
| 5421858 | WHITE BLOOD CELL COUNT INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5421858 | FGN |
| 5421858 | HP |
| 5421858 | LIT |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5421858 | 1008833726 | 1 | MON |